Protective Antibody Responses to Influenza A/H1N1/09 Vaccination in Children With Celiac Disease | Zendy

Schäppi Michela G. | Zendy; Meier Sara | Zendy; Bel Michael | Zendy; Siegrist ClaireAnne | Zendy; PosfayBarbe Klara M. | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Protective Antibody Responses to Influenza A/H1N1/09 Vaccination in Children With Celiac Disease

Author(s) -

Schäppi Michela G.,

Meier Sara,

Bel Michael,

Siegrist ClaireAnne,

PosfayBarbe Klara M.

Publication year - 2012

Publication title -

journal of pediatric gastroenterology and nutrition

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.206

H-Index - 131

eISSN - 1536-4801

pISSN - 0277-2116

DOI - 10.1097/mpg.0b013e318248e7be

Subject(s) - medicine , disease , vaccination , titer , antibody titer , antibody response , immunology , pandemic , antibody , influenza vaccine , covid-19 , infectious disease (medical specialty)

Patients with celiac disease have an increased risk for severe influenza infection and they show less of a response to certain vaccine types. During the influenza A/H1N1/09 pandemic, we prospectively investigated pandemic vaccine responses in 14 pediatric patients with celiac disease and age‐/sex‐matched controls. All of the children with celiac disease reached protective antibody titers (≥40) and showed a geometric mean titer comparable with the control group (530 vs 573).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research